1. Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease
Nowak et al. Am J Nephrol 2016;44: (DOI: / )
Table 1. Clinical characteristics of VEO and non-VEO patients with ADPKD at the final time point

2. Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease
Nowak et al. Am J Nephrol 2016;44: (DOI: / )
Table 2. Median time to events for included VEO and non-VEO patients with ADPKD

3. Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease
Nowak et al. Am J Nephrol 2016;44: (DOI: / )
Fig. 1. Kaplan-Meier curve of hypertension (a), htTKV ≥600 ml/m (b), glomerular hyperfiltration (eGFR ≥140 ml/min/1.73 m2; c) and eGFR <90 ml/min/1.73 m2 (d) according to group (VEO or non-VEO ADPKD). VEO patients were more likely to develop hypertension, to progress to htTKV >600 ml/m and to decline to eGFR <90 ml/min/1.73 m2 than non-VEO patients, but did not differ in progression to glomerular hyperfiltration.